Thiéry De Serres-Bérard

Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1

M. Boutjdir, J. Puymirat, M. Chahine, 2022, International journal of molecular sciences.

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

J. Puymirat, F. Rigo, C. Bennett, 2022, Gene therapy.